PWM
NVCR icon

Prosperity Wealth Management’s NovoCure NVCR Stock Holding History

Prosperity Wealth Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,710
Closed -$190K – 277
2025
Q3 		$190K Buy
+14,710
New +$197K 0.06% 235

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Prosperity Wealth Management's NVCR Position: Q4 2025 in Review

Prosperity Wealth Management sold out of NovoCure (NVCR) in Q4 2025, closing a stake of 14,710 shares — an estimated $190K sold.

Prosperity Wealth Management first reported a position in NVCR in Q3 2025 and held it in 1 quarter. The position peaked at $190K in Q3 2025. 238 funds tracked by Wall St. Rank hold NVCR as of Q4 2025.

  • Prosperity Wealth Management reported no remaining NovoCure position as of Q4 2025 after selling out during the quarter.
  • Prosperity Wealth Management sold 14,710 NovoCure shares in Q4 2025, an estimated $190K.
  • Prosperity Wealth Management first reported a position in NovoCure in Q3 2025 and held it in 1 quarter.
  • Prosperity Wealth Management's NovoCure position peaked at $190K in Q3 2025.
  • 238 funds tracked by Wall St. Rank held NovoCure as of Q4 2025.

Based on Prosperity Wealth Management's 13F filing for Q4 2025, filed 27 Mar 2026.